The DNA mismatch repair protein, MSH6 is a novel regulator of PD-L1 expression
Immune checkpoint inhibitors (ICIs) are extremely effective in a subgroup of mismatch repair-deficient (MMRd) cancers, but ∼50% remain resistant to treatment. We have shown for the first time that this may be due to the differential regulation of factors linked to response to ICIs upon loss of the d...
Saved in:
| Main Authors: | Kirsten Brooksbank, Charlotte Smith, Eleni Maniati, Amy Gibson, Wai Yiu Tse, Amy Kate Hall, Jun Wang, Tyson V Sharp, Sarah A Martin |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-09-01
|
| Series: | Neoplasia: An International Journal for Oncology Research |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S1476558625000879 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
DNA mismatch repair defect and intratumor heterogeneous deficiency differently impact immune responses in diffuse large B-cell lymphoma
by: Zijun Y. Xu-Monette, et al.
Published: (2024-12-01) -
MSH2 is not required for either maintenance of DNA methylation or repeat contraction at the FMR1 locus in fragile X syndrome or the FXN locus in Friedreich’s ataxia
by: Jessalyn Grant-Bier, et al.
Published: (2025-04-01) -
IMMUNOHISTOCHEMICAL STUDY OF MSH2, MSH6, PMS2, MLH1 IN EVALUATION OF DIFFERENTIATION GRADE OF COLON ADENOCARCINOMA
by: G. A. Raskin, et al.
Published: (2016-02-01) -
Inhibition of Melanogenesis via Passive Immune Targeted Alpha-MSH Binder Polypeptide
by: Se-Hyo Jeong, et al.
Published: (2025-01-01) -
Relative radiosensitivity of Arabidopsis thaliana Atmsh2 SALK_002708 mutant in the sublethal dose range of radiation
by: S. V. Litvinov, et al.
Published: (2018-06-01)